Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Epicore Bionetworks Inc. V.EBN

"Epicore Bionetworks Inc develops, manufactures and markets biotechnology products based on natural microbes and enzymes for the aquaculture, agriculture and municipal industries."


TSXV:EBN - Post by User

Comment by linpawson Dec 01, 2016 8:22pm
72 Views
Post# 25543916

RE:RE:Decent New Q numbers, esp. revenues

RE:RE:Decent New Q numbers, esp. revenues
Numbers are solid for this quarter but they will continue to encounter some rough times as long as shrimp prices are low. They are starting to increase in Asia so I expect 2017 will be a good year for them.

On the flip side, their MD&A is so poorly written. Not sure what has changed, but whoever wrote this discussion needs a serious lesson in grammar and sentence formation. It bothers me that management didn't see glaring issue in how it is written. Further, they seem to write the same information in each quarters discussion. They need to show a little more analysis when writing the report rather than regurgitating the same information year over year.
<< Previous
Bullboard Posts
Next >>